Literature DB >> 15908435

Imaging epidermal growth factor receptor phosphorylation in human colorectal cancer cells and human tissues.

Michael Keese1, Richard J Magdeburg, Torsten Herzog, Till Hasenberg, Martin Offterdinger, Rainer Pepperkok, Jörg W Sturm, Philippe I H Bastiaens.   

Abstract

In tumor cells, high phosphorylation levels of receptor tyrosine kinases may occur in the absence of exogenous ligands due to autocrine signaling or enhanced tyrosine kinase activity. Here we show that the phosphorylation state of the endogenous epidermal growth factor receptor (EGFR) can be quantitatively imaged in tumor cells and tissues by detecting fluorescence resonance energy transfer between fluorophores conjugated to antibodies against the receptor and phosphotyrosine, respectively. Five different human colorectal cell lines were analyzed for activity and expression of EGFR. All cell lines exhibited basal EGFR phosphorylation under serum starvation conditions. Phosphorylation levels increased after stimulation with EGF or pervanadate, dependent on the level of basal EGFR phosphorylation in the respective cell lines. This basal activity correlated inversely with receptor expression. Using the acceptor photobleaching fluorescence resonance energy transfer imaging approach, a significantly higher phosphorylation state of EGFR was also found in resected human colorectal tumor samples as compared with adjacent healthy tissue. Imaging of EGFR phosphorylation may thus serve as a valuable tool to investigate the role of receptor tyrosine kinase activity in malignant cell growth.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15908435     DOI: 10.1074/jbc.M504485200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Oxidation and nitration in dopaminergic areas of the prefrontal cortex from patients with bipolar disorder and schizophrenia.

Authors:  Helena Kyunghee Kim; Ana Cristina Andreazza; Pok Yik Yeung; Cameron Isaacs-Trepanier; L Trevor Young
Journal:  J Psychiatry Neurosci       Date:  2014-07       Impact factor: 6.186

2.  EGFR expression is linked to osteopontin and Nf-κB signaling in clear cell renal cell carcinoma.

Authors:  K Matušan-Ilijaš; G Damante; D Fabbro; G Dorđević; I Hadžisejdić; M Grahovac; M Avirović; B Grahovac; N Jonjić; K Lučin
Journal:  Clin Transl Oncol       Date:  2012-07-24       Impact factor: 3.405

3.  Analysis of the anti-tumor effect of cetuximab using protein kinetics and mouse xenograft models.

Authors:  Teppei Matsuo; Satoshi S Nishizuka; Kazushige Ishida; Takeshi Iwaya; Miyuki Ikeda; Go Wakabayashi
Journal:  BMC Res Notes       Date:  2011-05-10

4.  Displayed correlation between gene expression profiles and submicroscopic alterations in response to cetuximab, gefitinib and EGF in human colon cancer cell lines.

Authors:  Rossella Solmi; Mattia Lauriola; Mirko Francesconi; Désirée Martini; Manuela Voltattorni; Claudio Ceccarelli; Giampaolo Ugolini; Giancarlo Rosati; Simone Zanotti; Isacco Montroni; Gabriella Mattei; Mario Taffurelli; Donatella Santini; Furio Pezzetti; Alessandro Ruggeri; Gastone Castellani; Lia Guidotti; Domenico Coppola; Pierluigi Strippoli
Journal:  BMC Cancer       Date:  2008-08-08       Impact factor: 4.430

5.  Molecular determination of epidermal growth factor receptor in normal and neoplastic colorectal mucosa.

Authors:  G Piazzi; P Paterini; C Ceccarelli; M A Pantaleo; G Biasco
Journal:  Br J Cancer       Date:  2006-10-31       Impact factor: 7.640

Review 6.  Quantification of HER family receptors in breast cancer.

Authors:  Paolo Nuciforo; Nina Radosevic-Robin; Tony Ng; Maurizio Scaltriti
Journal:  Breast Cancer Res       Date:  2015-04-09       Impact factor: 6.466

7.  Detecting intratumoral heterogeneity of EGFR activity by liposome-based in vivo transfection of a fluorescent biosensor.

Authors:  G Weitsman; N J Mitchell; R Evans; A Cheung; T L Kalber; R Bofinger; G O Fruhwirth; M Keppler; Z V F Wright; P R Barber; P Gordon; T de Koning; W Wulaningsih; K Sander; B Vojnovic; S Ameer-Beg; M Lythgoe; J N Arnold; E Årstad; F Festy; H C Hailes; A B Tabor; T Ng
Journal:  Oncogene       Date:  2017-02-06       Impact factor: 9.867

Review 8.  The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients.

Authors:  Muireann T Kelleher; Gilbert Fruhwirth; Gargi Patel; Enyinnaya Ofo; Frederic Festy; Paul R Barber; Simon M Ameer-Beg; Borivoj Vojnovic; Cheryl Gillett; Anthony Coolen; György Kéri; Paul A Ellis; Tony Ng
Journal:  Target Oncol       Date:  2009-09-16       Impact factor: 4.493

Review 9.  Immunohistochemical assessment of protein phosphorylation state: the dream and the reality.

Authors:  James W Mandell
Journal:  Histochem Cell Biol       Date:  2008-07-22       Impact factor: 4.304

10.  Identification of the angiogenic gene signature induced by EGF and hypoxia in colorectal cancer.

Authors:  Tak L Khong; Ngayu Thairu; Helene Larsen; Peter M Dawson; Serafim Kiriakidis; Ewa M Paleolog
Journal:  BMC Cancer       Date:  2013-11-02       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.